Forschung

Markaki I, Bergström S, Tsitsi P, Remnestål J, Månberg A, Hertz E, Paslawski W, Sorjonen K, Uhlén M, Mangone G, Carvalho S, Rascol O, Meissner WG, Magnin E, Wüllner U, Corvol JC, Nilsson P, Svenningsson P. Cerebrospinal Fluid Levels of Kininogen-1 Indicate Early Cognitive Impairment in Parkinson's Disease. Mov Disord. 2020 Aug 15. doi: 10.1002/mds.28192. Online ahead of print. PMID: 33179332

Wüllner U. [Magnetic resonance tomography controlled focused ultrasound (MRgFUS) for tremor]. Fortschr Neurol Psychiatr. 2020 Sep;88(9):582-585. doi: 10.1055/a-1227-6211. Epub 2020 Sep 21. PMID: 32957143 Review. German.

Keil VC, Bakoeva SP, Jurcoane A, Doneva M, Amthor T, Koken P, Mädler B, Lüchters G, Block W, Wüllner U, Hattingen E. A pilot study of magnetic resonance fingerprinting in Parkinson's disease. NMR Biomed. 2020 Nov;33(11):e4389. doi: 10.1002/nbm.4389. Epub 2020 Aug 11. PMID: 32783321

Woitalla D, Krüger R, Lorenzl S, Müller T, Oelwein G, Storch A, Wolz M, Wüllner U. [The role of inhibitors of COMT and MAO-B in the therapy of Parkinson's disease]. Fortschr Neurol Psychiatr. 2020 Sep;88(9):620-633. doi: 10.1055/a-1149-9308. Epub 2020 Jun 25. PMID: 32588409 Review. German.

Sharma A, Weber D, Raupbach J, Dakal TC, Fließbach K, Ramirez A, Grune T, Wüllner U. Advanced glycation end products and protein carbonyl levels in plasma reveal sex-specific differences in Parkinson's and Alzheimer's disease. Redox Biol. 2020 Jul;34:101546. doi: 10.1016/j.redox.2020.101546. Epub 2020 May 18. PMID: 32460130 Free PMC article.